OC 60.3 Prevention of Hemorrhage after Implantation of Mechanical Circulatory Support with a Purified Von Willebrand Factor Concentrate: Results of the Early Terminated Randomized Controlled PHAM Trial

Antoine Rauch, Antoine Rauch, Guillaume Lebreton, Guillaume Lebreton, Mouhamed Djahoum Moussa, Mouhamed Djahoum Moussa, André Vincentelli, André Vincentelli, Erwan Flécher, Erwan Flécher, Olivier Bouchot, Olivier Bouchot, C. Dambrin, C. Dambrin, Bertrand Rozec, Bertrand Rozec, Laurent Barandon, Laurent Barandon, Emmanuelle Jeanpierre, Emmanuelle Jeanpierre, Nadine Ajzenberg, Nadine Ajzenberg, Yohann Repessé, Yohann Repessé, Emmanuel de Maistre, Emmanuel de Maistre, Piérre Siè, Piérre Siè, David M. Smadja, David M. Smadja, Fabienne Nédelec-Gac, Fabienne Nédelec-Gac, Sophie Voisin, Sophie Voisin, Silvy Laporte, Silvy Laporte, Julien Labreuche, Julien Labreuche, Sophie Susen, Sophie Susen (2023). OC 60.3 Prevention of Hemorrhage after Implantation of Mechanical Circulatory Support with a Purified Von Willebrand Factor Concentrate: Results of the Early Terminated Randomized Controlled PHAM Trial. , 7, DOI: https://doi.org/10.1016/j.rpth.2023.100549.